Larimar Therapeutics Reports Second Quarter 2025 Financial Results

Go back to Larimar Therapeutics Reports Second Quarter 2025 Financial Results
(NASDAQ: LRMR) Delayed: 3.64 +0.10 (2.82%)
Previous Close $3.54    52 Week High
Open $3.62    52 Week Low
Day High $3.76    P/E N/A 
Day Low $3.49    EPS
Volume 3,506,622